What happens when a kidney becomes available? - PowerPoint PPT Presentation

1 / 9
About This Presentation
Title:

What happens when a kidney becomes available?

Description:

What happens when a kidney becomes available? Bridget Montague UKT Registration Requirements ABO group Tissue Type: HLA A, B, C, DR, DQ Lymphocytotoxic antibody ... – PowerPoint PPT presentation

Number of Views:36
Avg rating:3.0/5.0
Slides: 10
Provided by: bapnOrgas
Learn more at: https://bapn.org
Category:

less

Transcript and Presenter's Notes

Title: What happens when a kidney becomes available?


1
What happens when a kidney becomes available?
  • Bridget Montague

2
UKT Registration
  • Requirements
  • ABO group
  • Tissue Type HLA A, B, C, DR, DQ
  • Lymphocytotoxic antibody status
  • Unacceptable antigens

3
  • Regular lymphocytotxic antibody screening is
    essential to prevent unexpected positive
    crossmatches at time of possible transplant
  • Antibodies can be screened by
  • Serology requires large panels of cells of
    known Tissue Type either by CDC or Flow Cytometry
  • ELISA antigen is attached to polystyrene plates
  • Luminex technology using beads coated either in
    groups of antigens or single antigens
  • Patients on the waiting list should be screened
    every three months or more frequently if they
    receive a transfusion.

4
Local donors
  • Sample are sent to the laboratory urgently
  • Tests performed
  • Class I and II typing by serology and molecular
    methods
  • Blood group
  • Transplant co-ordinator sends sample to
    Microbiology laboratories for screening for HIV,
    HBsAg, HBcAb, HCV, CMV and Syphillis

5
Local donors 2
  • When all results are complete they are faxed to
    UKT using their standard form
  • UKT will the perform a matching run
  • Kidneys are offered to patients according to the
    current allocation scheme
  • Tier A 000 mismatched paeds highly sensitised
    or HLA-DR homozygous
  • Tier B 000 mismatched paeds other
  • Tier C 000 mismatched adults highly sensitised
    or HLA-DR homozygous

6
Local donors 3
  • Tier D 000 mismatched adult patients others and
    favourably matched paeds (100, 010, 110
    mismatches)
  • Tier E all other eligible patients
  • Patients also prioritised according to waiting
    time
  • HLA match and age combined
  • Donor- recipient age difference
  • Location of patient relative to donor
  • HLA-DR homozygosity
  • HLA-B homozygosity
  • Blood group match

7
Donor becomes available
  • Samples are received by the laboratory from the
    recipient for crossmatching
  • Lymph node and / or spleen samples are received
    from the donor
  • If the donor is an import UKT will fax the Tissue
    Typing results to the laboratory
  • Procedure for local donors
  • Blood group confirmation performed using rbc
    obtained from spleen sample

8
Donor becomes available 2
  • Lymphocyotoxic crossmatch performed using
    patients serum sample(s) (current and highest
    frequency historical serum if patient is
    sensitised) and donor lymphocytes
  • Allo and auto crossmatch performed by CDC
  • Allo only by Flow Cytometry
  • Results interpreted according to laboratory
    protocol and policies

9
Donor becomes available 3
  • A paper report produced at time of crossmatch is
    faxed to the ward and receipt confirmed by
    telephone
  • A final copy report is sent to the consultant
  • Procedure for imported donors
  • Exactly the same but the donor is HLA Class I and
    II typed by serology at the time
  • Donor HLA-C and DR/DQ are confirmed by molecular
    methods before the final report is issued.
Write a Comment
User Comments (0)
About PowerShow.com